<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iajabms</journal-id><journal-id journal-id-type="pubmed">IAJABMS</journal-id><journal-id journal-id-type="publisher">IAJABMS</journal-id><issn>2709-3298</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iajabms.2026.v07i01.002</article-id><title-group><article-title>Serum IL-22, miRNA-146a Expression and Total Antioxidant Status as Integrated Biomarkers in Rheumatoid Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Khalid R.</given-names><surname>Kareem</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><aff-id id="aff-a">1Iraq</aff-id><abstract>&amp;nbsp;Background:&amp;nbsp;Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent inflammation of the synovial joints. Over time, this inflammatory process contributes to cartilage destruction, bone erosion, functional impairment and several extra-articular complications [1,2]. Current evidence indicates that RA pathogenesis is not driven by a single mechanism, but rather by a complex interaction among cytokine dysregulation, epigenetic changes and oxidative stress. Objective: This study was designed to organize, analyze and interpret the available findings concerning serum IL-22, miRNA-146a relative expression and total antioxidant status in patients with RA compared with healthy controls, with particular attention to their biological significance and potential diagnostic value. Methods: A case-control dataset including 40 RA patients and 40 controls was analyzed. The previously excluded immunological variables were removed from the analysis according to the revised study plan.IL-22 was detected by ELISA Technique, whereas miRNA was restricted by qPCR and spectrophotometer was used to estimate total antioxidant. Statistical analysis was performed in an SPSS-style framework using descriptive statistics, independent-samples comparisons, Spearman correlation and Kruskal-Wallis testing where appropriate. Results: Patients with RA exhibited increased levels of all three investigated biomarkers when compared with the control group. Among these markers, miRNA-146a showed the greatest relative change, followed by total antioxidant status and IL-22. The reported ROC analysis indicated excellent diagnostic performance for miRNA-146a and total antioxidant status, whereas IL-22 demonstrated only moderate to borderline discriminatory ability. Conclusion: The available data suggest that miRNA-146a, IL-22 and total antioxidant status may collectively reflect an interconnected epigenetic, inflammatory and redox-related profile in RA. Among the studied biomarkers, miRNA-146a appeared to be the most informative indicator in the supplied dataset. However, further confirmation using original participant-level data and an independent validation cohort is still required before final journal submission.</abstract></article-meta></front><body /><back /></article>